On the upside
The FDA approved a pulmonary embolism device to be made by Angiotech Pharmaceuticals (Nasdaq: ANPI).
Biotechnology company Micromet (Nasdaq: MITI) reported positive results for its drug candidate that treats leukemia.
On the downside
Palm (Nasdaq: PALM) attracted strong foot traffic over the weekend at Sprint (NYSE: S) stores, but analysts were concerned about the limited supply of Pre smart phones.
Barnes Group (NYSE: B) was downgraded by an analyst on concerns that turmoil in the automotive industry may affect the component manufacturer.
Shares of DuPont (NYSE: DD) fell despite an analyst reiterating his rating for the chemical company. Investors worried about reduced purchases from General Motors.
In the broad market, declining issues outpaced advancers by a margin of more than 3 to 1 on the NYSE and by more than 2 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks lost 7 points to 522.